Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep679 | Female Reproduction | ECE2016

Evaluation of serum osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in obese and non-obese patients with polycystic ovary syndrome

Tutal Esra , Arslan Muyesser Sayki , Karakose Melia , Demirci Taner , Cakal Erman , Ozbek Mustafa , Erden Gonul , Delibasi Tuncay

Introduction: Polycystic ovary syndrome (PCOS) is a common endocrinopathy associated with increased cardiovascular risk in reproductive aged women. Circulating osteoprotegerin (OPG) and soluble receptor activator of nuclear factor κB ligand (sRANKL) are associated with subclinical atherosclerosis. Our aim is to evalutate serum OPG and sRANKL levels and their relations with cardiovascular and metabolic markers in paients with obese and non-obese PCOS.<p class="abstext"...